Carter Bankshares vs Capital Bancorp
CARE and CBNK side by side, both in commercial banks. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CARE and CBNK compare
Carter Bankshares and Capital Bancorp are about the same size, with market caps of $650M and $686M.
On earnings, Carter Bankshares is cheaper: it trades at 5.0× trailing earnings, against 12.7× for Capital Bancorp.
Carter Bankshares grew revenue faster over the last twelve months (76.9% versus 8.5% for Capital Bancorp).
Carter Bankshares keeps more of each dollar of sales as profit, with a net margin of 50.0% compared with 21.0% at Capital Bancorp.
Both pay dividends: Carter Bankshares yields 1.0% and Capital Bancorp 1.2%.
Carter Bankshares scores higher on the StockData Score (15 against 12 for Capital Bancorp), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CARE | CBNK |
|---|---|---|
| Size and price | ||
| Market cap | $650M | $686M |
| Share price | $29.32 | $42.12 |
| Change, 1 year | 66.8% | 50.6% |
| Change, 5 years | 89.8% | 56.0% |
| Beta (5Y) | 0.60 | 0.61 |
| Employees | 687 | 459 |
| StockData Score | ||
| Total score | 15 (better) | 12 |
| Valuation score | 6 (better) | 1 |
| Growth score | 1 | 1 |
| Performance score | 3 | 3 |
| Health score | 4 | 4 |
| Dividend score | 1 | 3 (better) |
| Valuation | ||
| P/E | 5.0× (better) | 12.7× |
| P/S | 2.5× (better) | 2.7× |
| P/B | 1.2× (better) | 1.6× |
| P/FCF | 13.4× | – |
| PEG | – | 2.34 |
| FCF yield | 7.5% | – |
| Fair value | $50.89 | $34.96 |
| Margin of safety | 42.4% (better) | −20.5% |
| Growth | ||
| Revenue growth (TTM) | 76.9% (better) | 8.5% |
| Revenue growth, 5Y average | 2.5% | 12.8% (better) |
| Net income growth (TTM) | 320% (better) | 9.6% |
| EPS growth (TTM) | 335% (better) | 12.6% |
| EPS growth, 5Y average | – | 12.8% |
| Profitability | ||
| Net margin | 50.0% (better) | 21.0% |
| FCF margin | 18.5% | – |
| Return on equity | 27.9% (better) | 13.2% |
| Financial health | ||
| Altman Z-score | 0.29 | 0.31 (better) |
| Piotroski F-score | 7 (better) | 5 |
| Dividends and buybacks | ||
| Dividend yield | 1.0% | 1.2% (better) |
| Payout ratio | – | 15.0% |
| Years of dividend growth | – | 4 |
| Buyback yield | – | 1.8% |
| Shareholder yield | 1.0% | 3.0% (better) |
| Ownership | ||
| Held by institutions | 65.5% | 45.4% |
| Held by insiders | 4.4% | 25.6% |
| Insider net buying, 12 months | −$253K | $0 (better) |
| Short interest, % of float | 11.4% | 4.5% |
Go deeper
- CARE stock overview
- CARE income statement
- CARE valuation and score
- CBNK stock overview
- CBNK income statement
- CBNK valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.